MSAC rejected a new breast cancer diagnostic after receiving a late submission from a competitor - through a former committee member - that it did not disclose to the applicant. It also delayed the release of the Public Summary Document while it worked on evidence to support the rejection.
Latest Video
New Stories
-
New research uncovers Australian women are often reluctant to openly talk about menopause
October 18, 2024 - - Latest News -
The danger of this outlier is reflected in the disconnect with another policy process
October 18, 2024 - - Latest News -
Pharmac seeking bids from suppliers of COVID-19 vaccines
October 17, 2024 - - Latest News -
Auditor General launches audit of the procurement of onshore vaccine manufacturing facilities
October 17, 2024 - - Latest News -
This has happened before and the response should be the same. No.
October 17, 2024 - - Latest News -
Vitalis and Servita partner to lead healthcare digital transformation in Queensland
October 17, 2024 - - Latest News -
Commercial Eyes signs new AI-focused service agreement with Opyl
October 17, 2024 - - Latest News